Mizota Tamotsu | Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
スポンサーリンク
概要
- Mizota Tamotsuの詳細を見る
- 同名の論文著者
- Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.の論文著者
関連著者
-
Kawamura Ikuo
Department Of Bacteriology Niigata University School Of Medicine
-
Shimomura Kyoichi
Department Of Pharmacology Pharmacological Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Kohsaka Masanobu
Department of Pharmacology, Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Mizota Tamotsu
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Tanaka Yoshio
Department Of Applied Chemistry Faculty Of Engineering Yokohama National University
-
MANDA Toshitaka
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo
-
KONDO Naomi
Department of Paediatrics, Gifu University School of Medicine
-
Kohsaka Masanobu
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa-ku, Osaka 532, Japan
-
Manda Toshitaka
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa-ku, Osaka 532, Japan
-
Lacey Elizabeth
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa-ku, Osaka 532, Japan
-
SHIMOMURA Kyoichi
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Kawamura Ikuo
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Kawamura Ikuo
Department of Pharmacology, Product Development Laboratories, Fujisawa Pharmaceutical Co., Ltd., 2-1-6, Kashima, Yodogawa-ku, Osaka 532, Japan
著作論文
- Antitumor Effects of Droloxifene, a New Antiestrogen Drug, against 7, 12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Rats.
- The Estrogenic and Antiestrogenic Activities of Droloxifene in Human Breast Cancers.